Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.

Tran PT, Lowe K, Tsai HL, Song DY, Hung AY, Hearn JWD, Miller S, Proudfoot JA, Deek MP, Phillips R, Lotan T, Paller CJ, Marshall CH, Markowski M, Dipasquale S, Denmeade S, Carducci M, Eisenberger M, DeWeese TL, Orton M, Deville C, Davicioni E, Liauw SL, Heath EI, Greco S, Desai NB, Spratt DE, Feng F, Wang H, Beer TM, Antonarakis ES

Open source

DOI: 10.1200/jco.22.01662
Published: 2023 Feb 20
Container: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco.22.01662,
  title = {Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.},
  author = {Tran PT and Lowe K and Tsai HL and Song DY and Hung AY and Hearn JWD and Miller S and Proudfoot JA and Deek MP and Phillips R and Lotan T and Paller CJ and Marshall CH and Markowski M and Dipasquale S and Denmeade S and Carducci M and Eisenberger M and DeWeese TL and Orton M and Deville C and Davicioni E and Liauw SL and Heath EI and Greco S and Desai NB and Spratt DE and Feng F and Wang H and Beer TM and Antonarakis ES},
  year = {2023},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco.22.01662},
  url = {https://doi.org/10.1200/jco.22.01662}
}

RIS

TY  - JOUR
TI  - Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.
AU  - Tran PT
AU  - Lowe K
AU  - Tsai HL
AU  - Song DY
AU  - Hung AY
AU  - Hearn JWD
AU  - Miller S
AU  - Proudfoot JA
AU  - Deek MP
AU  - Phillips R
AU  - Lotan T
AU  - Paller CJ
AU  - Marshall CH
AU  - Markowski M
AU  - Dipasquale S
AU  - Denmeade S
AU  - Carducci M
AU  - Eisenberger M
AU  - DeWeese TL
AU  - Orton M
AU  - Deville C
AU  - Davicioni E
AU  - Liauw SL
AU  - Heath EI
AU  - Greco S
AU  - Desai NB
AU  - Spratt DE
AU  - Feng F
AU  - Wang H
AU  - Beer TM
AU  - Antonarakis ES
PY  - 2023
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco.22.01662
UR  - https://doi.org/10.1200/jco.22.01662
ER  -

APA

PT, T., K, L., HL, T., DY, S., AY, H., JWD, H., S, M., JA, P., MP, D., R, P., T, L., CJ, P., CH, M., M, M., S, D., S, D., M, C., M, E., TL, D., M, O., C, D., E, D., SL, L., EI, H., S, G., NB, D., DE, S., F, F., H, W., TM, B., & ES, A. (2023). Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco.22.01662

Source records

pubmed · retrieved 2026-09-25T18:27:15.432Z